Effect of parathyroid hormone and interleukin-1 alpha in osteoblastic MC3T3-E1 cells: interaction with beta-alanyl-L-histidinato zinc.
beta-Alanyl-L-histidinato zinc (AHZ), which is an activator of bone formation, has an inhibitory effect of bone resorption. Whether AHZ can inhibit the effect of parathyroid hormone (PTH) or interleukin-1 alpha (IL-1 alpha), which is a bone resorbing factor, on osteoblastic MC3T3-E1 cells was investigated. After subculture for 3 days, the cells were cultured for 48 h with peptides. Parathyroid hormone (10(-9)-10(-7) M) or IL-1 alpha (50 U/ml) caused a significant decrease in the cellular alkaline phosphatase activity and a remarkable increase of prostaglandin E2 (PGE2) production in the cells. Parathyroid hormone (10(-7) M) or IL-1 alpha (50 U/ml) did not have an appreciable effect on the protein content of the cells. beta-Alanyl-L-histidinato zinc (10(-5) M) significantly increased the cellular alkaline phosphatase activity and protein content, whereas it had no effect on PGE2 production. This increasing effect of AHZ was also seen in the presence of PTH (10(-7) M) or IL-1 alpha (50 U/ml), although the effect of PTH and IL-1 alpha to stimulate PGE2 production was not modulated by AHZ treatment. The present finding suggests that the inhibitory effect of AHZ on bone resorption is not through osteoblasts.
Yamaguchi
M
M
Laboratory of Metabolism and Endocrinology, Graduate School of Nutritional Sciences, University of Shizuoka, Japan.
Hashizume
M
M
D000469:Alkaline Phosphatase / Q000037:antagonists & inhibitors; D001862:Bone Resorption / Q000517:prevention & control*; D002336:Carnosine / Q000031:analogs & derivatives*; D002460:Cell Line; D015232:Dinoprostone / Q000096:biosynthesis; D004151:Dipeptides / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007773:Lactates / Q000096:biosynthesis; D019344:Lactic Acid; D009942:Organometallic Compounds / Q000494:pharmacology*; D010006:Osteoblasts / Q000187:drug effects*; D010281:Parathyroid Hormone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011506:Proteins / Q000187:drug effects / Q000378:metabolism; D015032:Zinc; D017967:Zinc Compounds
D004151:Dipeptides; D007375:Interleukin-1; D007773:Lactates; D009942:Organometallic Compounds; D010281:Parathyroid Hormone; D011506:Proteins; D017967:Zinc Compounds; C061957:polaprezinc; D019344:Lactic Acid; D002336:Carnosine; D000469:Alkaline Phosphatase; D005947:Glucose; D015032:Zinc; D015232:Dinoprostone